Deutsche Bank’s Intellipharmaceuticals International Inc. IPCI Stock Holding History
Bought
Maintained
Sold
Other funds holding IPCI
AC
AFM
VF
ATC
AG
BAM
VAM
Deutsche Bank's IPCI Position: Q1 2018 in Review
Deutsche Bank sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2018, closing a stake of 681 shares — an estimated $5K sold.
Deutsche Bank first reported a position in IPCI in Q2 2013 and held it in 19 quarters. The position peaked at $857K in Q4 2013. 24 funds tracked by Wall St. Rank hold IPCI as of Q1 2018.
- Deutsche Bank reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2018 after selling out during the quarter.
- Deutsche Bank sold 681 Intellipharmaceuticals International Inc. shares in Q1 2018, an estimated $5K.
- Deutsche Bank first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 19 quarters.
- Deutsche Bank's Intellipharmaceuticals International Inc. position peaked at $857K in Q4 2013.
- 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2018.
Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.